F.Lee-LiuD.et al
Returning a partially used vial to the refrigerator may create condensation and accelerate degradation, compromising future doses
Presented at the American Heart Associations 2023 Scientific Sessions (1113 November, Philadelphia, USA), the results of the SELECT trial showed that overweight or obese people without diabetes taking semaglutide for more than three years had a 20% lower risk of heart attack, stroke or death due to cardiovascular disease and lost an average of 9.4% of their body weight
Hexarelin's unique value is in short-term, high-amplitude GH research and cardiac-focused models where its CD36 activity provides benefits no other GHRP can match
Multifunctionality and possible medical application of the BPC 157 peptideLiterature and patent review
One hGH variant with mono-PEGylation at residue 35, designated ARX201, presented favorable pharmacodynamic properties in GH-deficient rats, and comparable efficacy and safety to native hGH therapy, but with enhanced potency and reduced injection frequency, in adult GH-deficient patients